ATS 2018 International Conference

A Novel Dual Role for MEK Inhibitors as Modulators of Inflammation and Host Defense Mechanisms with Potential Therapeutic Application in COPD [Board No. 617]

Location: Board no. 617

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Wednesday

May

1:30 PM

3:30 PM

Speaker(s)/Author(s)

Outi Vaarala

M.D., Ph.D.
AstraZeneca;AstraZeneca RIA IMED Biotech Unit;Respiratory, Inflammation and Autoimmunity IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden

Taylor S. Cohen

PhD
Medimmune

Lisa Oberg

Masters of Science (MSc)
AstraZeneca;AstraZeneca RIA IMED Biotech Unit;Respiratory, Inflammation and Autoimmunity IMED Biotech Unit, AstraZeneca, Gothenburg, Sweden

Britta Bonn

PhD
AstraZeneca RIA IMED Biotech Unit

Gabriel Skogberg

PhD
AstraZeneca RIA IMED Biotech Unit

Paul D. Smith

PhD
Astrazeneca Oncology IMED Biotech Unit

Nisha Kurian

PhD
Astrazeneca PMG IMED Biotech Unit

Danen Cunoosamy

PhD
Astrazeneca RIA IMED Biotech Unit

View Abstract

A Novel Dual Role for MEK Inhibitors as Modulators of Inflammation and Host Defense Mechanisms with Potential Therapeutic Application in COPD

Parent Sessions

D101 - MECHANISTIC AND TRANSLATIONAL STUDIES IN COPD...
05-23-2018 1:30 PM - 3:30 PM

Event